Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples

被引:23
作者
Ngo, TH [1 ]
Verheyen, S [1 ]
Knockaert, I [1 ]
Declerck, PJ [1 ]
机构
[1] Catholic Univ Louvain, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
关键词
D O I
10.1055/s-0037-1615069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two enzyme-linked immunosorbent assays (ELISAs) for the quantitation of rat plasminogen activator inhibitor-1 (PAI-1) antigen and activity, respectively, in biological fluids were developed using monoclonal antibodies raised against recombinant rat PAI-1. These assays had a lower limit of sensitivity in plasma of 0.3 and 0.15 ng/ml, respectively. The intra-assay, inter-assay and inter-dilution coefficients of variation were 9, 14 and 9%, respectively, for the antigen assay and 8, 17 and 13%, respectively for the activity assay. Assay recoveries of recombinant rat PAI-1 (5 to 20 ng/ml) added to plasma were 73 to 88% and 89 to 93% for the antigen and the activity assay, respectively. The level of PAI-1 antigen in rat plasma was 1.8 +/- 0.9 ng/ml (mean +/- SD, n = 18), with a corresponding value of 1.0 +/- 0.5 ng/ml for PAI-1 activity. In lysed platelet-rich rat plasma PAI-1 antigen was 6.0 +/- 1.0 ng/ml (n = 8) and PAI-1 activity was 2.3 +/- 0.4 ng/ml (n = 8). Endotoxin injection (0.5 mg/kg) induced a time-dependent increase of both PAI-1 antigen and PAI-I activity levels in rat plasma, eventually resulting in a 100- to 200-fold increase (p <0.0001 vs, baseline). A linear correlation was found between PAI-1 antigen and activity levels in normal plasma (r = 0.63, n = 18, p <0.01) and in plasma from endotoxin-treated rats (r = 0.90, n = 35, p <0.001). Application of these assays for the analysis of gel filtration experiments of plasma from endotoxin-treated rats demonstrated that PAI-1 antigen eluted as two peaks (with corresponding Mr of similar to 430 kDa and 61 kDa) whereas PAI-1 activity eluted as a single peak corresponding with the high molecular weight antigen form. Thus, these unique assays allowing the specific determination of rat PAI-1 antigen and rat PAI-1 activity may constitute important tools for further investigations on the pathophysiological role of PAI-1 in a variety of experimental rat models.
引用
收藏
页码:808 / 812
页数:5
相关论文
共 34 条
  • [21] LEE MH, 1993, BLOOD, V81, P2357
  • [22] ANALYSIS OF PLATELET SURVIVAL CURVES IN AN ARTERIAL THROMBOSIS MODEL IN RATS
    MEULEMAN, DG
    VOGEL, GMT
    STULEMEYER, SM
    MOELKER, HCT
    [J]. THROMBOSIS RESEARCH, 1980, 20 (01) : 31 - 43
  • [23] EFFECTS OF INTRA-ARTERIAL CANNULATION ON BLOOD-PLATELET CONSUMPTION IN RATS
    MEULEMAN, DG
    VOGEL, GMT
    VANDELFT, AML
    [J]. THROMBOSIS RESEARCH, 1980, 20 (01) : 45 - 55
  • [24] PEROXIDASE-LABELED ANTIBODY - NEW METHOD OF CONJUGATION
    NAKANE, PK
    KAWAOI, A
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1974, 22 (12) : 1084 - 1091
  • [25] CHARACTERIZATION AND PURIFICATION OF A SECRETED PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) INDUCED BY TRANSFORMING GROWTH FACTOR-BETA-1 IN NORMAL RAT-KIDNEY (NRK) CELLS - DECREASED PAI-1 EXPRESSION IN TRANSFORMED NRK CELLS
    NEWMAN, MJ
    LANE, EA
    IANNOTTI, AM
    NUGENT, MA
    PEPINSKY, RB
    KESKIOJA, J
    [J]. ENDOCRINOLOGY, 1990, 126 (06) : 2936 - 2946
  • [26] Expression, purification, and characterization of recombinant rat plasminogen activator inhibitor-1
    Ngo, TH
    Bijnens, AP
    Knockaert, I
    Declerck, PJ
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (01): : 37 - 43
  • [27] SAMAMA M, 1985, THROMB HAEMOSTASIS, V54, P726
  • [28] BLEEDING DIATHESIS DUE TO DECREASED FUNCTIONAL-ACTIVITY OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    SCHLEEF, RR
    HIGGINS, DL
    PILLEMER, E
    LEVITT, LJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) : 1747 - 1752
  • [29] PLATELET SURVIVAL TIME FOLLOWING AORTIC-VALVE REPLACEMENT
    STEELE, P
    WEILY, H
    DAVIES, H
    PAPPAS, G
    GENTON, E
    [J]. CIRCULATION, 1975, 51 (02) : 358 - 362
  • [30] EFFECTS OF CLOFIBRATE AND SULFINPYRAZONE ON PLATELET SURVIVAL TIME IN CORONARY-ARTERY DISEASE
    STEELE, P
    BATTOCK, D
    GENTON, E
    [J]. CIRCULATION, 1975, 52 (03) : 473 - 476